Piramal Pharma Limited

NSE PPLPHARMA.NS

Piramal Pharma Limited Free Cash Flow Yield on January 14, 2025: 1.00%

Piramal Pharma Limited Free Cash Flow Yield is 1.00% on January 14, 2025, a 138.06% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Piramal Pharma Limited 52-week high Free Cash Flow Yield is 1.71% on April 01, 2024, which is 71.99% above the current Free Cash Flow Yield.
Piramal Pharma Limited 52-week low Free Cash Flow Yield is -3.20% on March 15, 2024, which is -420.98% below the current Free Cash Flow Yield.
Piramal Pharma Limited average Free Cash Flow Yield for the last 52 weeks is 0.38%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

NSE: PPLPHARMA.NS

Piramal Pharma Limited

CEO	Mr. Peter Daniel DeYoung
IPO Date	Oct. 19, 2022
Location	India
Headquarters	507, Skyline Wealth Space
Employees	6,719
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.

Key trends

Past 5 years